How to buy SOPHiA GENETICS stock (SOPHiA Genetics)

SOPHiA GENETICS is a health information services business based in the US. SOPHiA GENETICS shares (SOPH) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.36 – an increase of 3.07% over the previous week. SOPHiA GENETICS employs 430 staff and has a trailing 12-month revenue of around $64.5 million.

Our top picks for where to buy Sophia Genetics stock

Buy SOPHiA GENETICS stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

SOPHiA GENETICS stock price (NASDAQ: SOPH)

Use our graph to track the performance of SOPH stocks over time.

SOPHiA GENETICS shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$3.36
52-week range	$2.70 - $7.37
50-day moving average more info button	$3.42
200-day moving average more info button	$4.17
Wall St. target price	$7.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.09

Is it a good time to buy SOPHiA GENETICS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SOPHiA GENETICS price performance over time

Historical closes compared with the close of $3.19 from 2024-12-26

1 week (2024-12-20)	-2.15%
1 month (2024-11-27)	-2.45%
3 months (2024-09-27)	-14.48%
6 months (2024-06-28)	-30.35%

1 year (2023-12-28)	-34.23%
2 years (2022-12-28)	23.17%
3 years (2021-12-27)	13.22
5 years (2019-12-24)	N/A

SOPHiA GENETICS financials

Revenue TTM	$64.5 million
Gross profit TTM	$31.3 million
Return on assets TTM	-22.18%
Return on equity TTM	-52.51%
Profit margin	-110.71%
Book value	$1.71
Market Capitalization more info button	$209.9 million

TTM: trailing 12 months

SOPHiA GENETICS share dividends

We're not expecting SOPHiA GENETICS to pay a dividend over the next 12 months.

You may also wish to consider:

• Becton Dickinson and Company (BDX.US) (1.75% forward annual dividend yield)

SOPHiA GENETICS share price volatility

Over the last 12 months, SOPHiA GENETICS's shares have ranged in value from as little as $2.7 up to $7.37. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SOPHiA GENETICS's is 1.032. This would suggest that SOPHiA GENETICS's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put SOPHiA GENETICS's beta into context you can compare it against those of similar companies.

• Becton Dickinson and Company (BDX.US): 0.45
• EXACT Sciences Corporation (EXAS.US): 1.272
• Biogen (BIIB.US): -0.061

SOPHiA GENETICS overview

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland. .

Frequently asked questions

What percentage of SOPHiA GENETICS is owned by insiders or institutions?
Currently 5.819% of SOPHiA GENETICS shares are held by insiders and 53.398% by institutions. How many people work for SOPHiA GENETICS?
Latest data suggests 430 work at SOPHiA GENETICS. When does the fiscal year end for SOPHiA GENETICS?
SOPHiA GENETICS's fiscal year ends in December. Where is SOPHiA GENETICS based?
SOPHiA GENETICS's address is: La PiEce 12, Rolle, Switzerland, 1180 What is SOPHiA GENETICS's ISIN number?
SOPHiA GENETICS's international securities identification number is: CH1125843347